DIAGNOSING ALZHEIMER’S DISEASE IN THE BLINK OF AN EYE
A Simple Eye Scan to Detect
Key Biomarkers of Alzheimer’s Disease.
This can change everything. Take a look.
We have a vision
By 2050, the number of people suffering from Alzheimer’s disease will have tripled, affecting a projected 13.8 million people in the US alone. Early detection of this horrible disease is crucial. We’re focused on a solution.
Innovation
Our team is developing a ground-breaking tool for identifying beta-amyloid (AB) plaques, a key biomarker of this disease.